A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)
Clinical trial NCT00535236 · COMPLETED
Trial details
- NCT number
- NCT00535236
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-02
- Primary completion
- 2010-01-25
- Enrollment
- 341
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.